chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever and body aches off; Fever and body aches off; This is a spontaneous report from a non- contactable consumer. A 27-years old non-pregnant-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EN-6208) in the arm right on 16Mar2021at 11:30 AM (age at vaccination- 27 years old) as a single dose for COVID-19 immunisation. Patient's concomitant medications included birth control pill (MANUFACTURER UNKNOWN), lexapro (MANUFACTURER UNKNOWN), claritin (MANUFACTURER UNKNOWN) for unknown indications from unspecified date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EM-9809) in the arm left on 23Feb2021 at 12:00 PM as a single dose for COVID-19 Immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The Patient did not have any allergies to medications, food, or other product. On 17Mar2021 at 1:00 PM the patient experienced fever and body aches off and on 24-36 hours following the second vaccination. The patient did not receive treatment for the events. The clinical outcome of fever and body aches were resolved.    No follow-up attempts are needed. No further information is expected.
Parent (Dad) called the County Health Department to report that at midnight on 02/27/2012 his daughter started to cough, wheeze, and had increased pulse, but no fever was noted.  Parent treated his daughter at home with "steamy shower", OTC Robitussin (which parent reported that he diluted with water).  He further reported that wheezing stopped after the child got out of the shower.  Parent did not take child to ER that evening.
Patient developed formication; followed by dyspnea, sensation of swelling of lips/throat, and nausea.
Hepatitis B vaccine was administered. Patient had previously had series of 3. Hepatitis A should have been given.
Blood pressure was high,  pain in left arm, lump and pain on my left shoulder blade, chills and low grade fever.  I took Tylenol and the chills and fever went away Friday night,  The pain in my arm went  away by Sunday, 4/25.  My blood pressure went down after drinking  more water.  I can still feel the lump but its not as painful.
The patient has redness and swelling on the right arm, not painful but little itchy after almost a week after the vaccine.
nausea; headache; The rash I had from first got worse. I had it everywhere on my limbs, body and my face was the worse; My face was very red and swollen.; My face was very red and swollen.; did not feel well.; This is a spontaneous report received from a contactable consumer (patient). A 65-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EN6202) via an unspecified route of administration at left arm on 26Feb2021 09:30 as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included sertraline hydrochloride (ZOLOFT), lorazepam (ATIVAN) and Vitamins. Patient do not have any other medical history and known allergies. Patient was not pregnant at the time vaccination. Patient did not receive any other vaccines within 4 weeks of time. Patient did not have COVID-19 prior to vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EL9266) via an unspecified route of administration at left arm on 05Feb2021 09:30 as dose 1, single for COVID-19 immunisation and experienced a mild rash on stomach and back. After second dose Feb2021, the patient experienced nausea, and headache for 4 days straight, the rash patient had from first got worse. patient had it everywhere on my limbs, body and her face was the worse. Her face was very red and swollen. It took almost 2 weeks for all symptoms to go away. During that two weeks, patient just did not feel well. Patient did not receive any treatment for the events. Since vaccination patient has not been tested for COVID-19. Outcome of event did not feel well was unknown and remaining all events was resolving.   No follow-up attempts are possible. No further information is expected.
Tachycardia and syncopal episode, no loss of consciousness. Tachycardia continued for ~2 hours. Both tachycardia and syncopal episodes ended after a few hours. Blood pressure low (96/62). Still low (98/72) but improving.
Client's mother called on 08/08/2007 to state that client had temp of 102 degrees fahrenheit and above even with tylenol or ibuprofen around the clock.  Client exhibited general malaise, and was subdued through out day, with decrease of appetite.  Advised to continue to hydrate in extreme heat, watch for signs of dehydration.  Physician contacted by phone, no visit, no actions at this time
flu; stomach issues due to changes in my liver bile; stomach issues due to changes in my liver bile; lethargy; low-grade fever; a headache every day; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 28Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: Apr2021, for Covid-19 Immunization; Bnt162b2 (Dose 2), administration date: May2021, for Covid-19 Immunization. The following information was reported: INFLUENZA (non-serious) with onset Jan2022, outcome "unknown", described as "flu"; ABDOMINAL DISCOMFORT (non-serious), LIVER DISORDER (non-serious) all with onset Jan2022, outcome "unknown" and all described as "stomach issues due to changes in my liver bile"; LETHARGY (non-serious) with onset Jan2022, outcome "unknown", described as "lethargy"; PYREXIA (non-serious) with onset Jan2022, outcome "unknown", described as "low-grade fever"; HEADACHE (non-serious) with onset Jan2022, outcome "unknown", described as "a headache every day".  Additional information: Patient took the first two Pfizer shots in Apr2021/May2021 without incident. After Booster (3rd shot) on 28Dec. 3 days later, had the flu, a headache every day, low-grade fever, lethargy, plus stomach issues due to changes in liver bile. Patient lost the entire month of Jan to this shot.  The lot number for bnt162b2 was not provided and will be requested during follow up.
At around 1730 on 22 Dec I began to experience significant  fatigue, muscle aches, outside of the injection site, headache and a fever above 101F.  This general condition lasted until 0200 on 24 Dec. persisting  issues at this juncture are muscle aches, fatigue and nausea.
Patient came in this morning and asked about her left arm. She had a red rash like we would expect but she had the vaccine on 04/14/2021 and today is the 26th. She stated it was actually getting larger and her arm hurt.
Aortic stenosis, severe - operation: Transfemoral Transcutaneous Aortic Valve Replacement with aortic valve prosthesis of a 29 mm Evolut Pro+. Post procedure the patient did very well. Admission within 6 weeks of receiving the COVID vaccine.
Severe reticular alopecia areata onset x1 week post vaccination. My brother is also experiencing new onset alopecia areata 2 weeks after receiving covid vaccine.
"Face, neck, chest, shoulders flushed and hot".  Pt took Zyrtec and Advil at home evening of 10/16/13 and used ice packs to sites. She states she "felt some better the next morning but after a hot shower the symptoms got worse extending bilat arms to wrists". Pt. states it felt like a "bad sunburn" and like her skin was "on fire".
11:30pm Right hand tightened up, pain, stiffness, since.  Had a cortisone shot in my Right Ring finger in June 2021, had no pain, no limited mobility, exercised daily, no symptoms.  After the vaccine, haven't been able to complete a full exercise routine.  Also had flu like symptoms for three days, 103.5 fever, cold sweats, no energy for weeks.
The patient received her second dose of the Pfizer vaccine at 1607, was directed to the observation area to be monitored for 15 minutes per pre-vaccination screening, and complained of dizziness during her discharge at approximately 1625.  First responders were onsite , vital signs were obtained and found to be WNL.  Patient was discharged at this time and advised to have her spouse come pick her up due to dizziness, which she verbalized understanding and agreement.  Prior to spouse arriving, patient began to c/o chest pain and difficulty breathing.  VS at 1645 were B/P 167/80, HR 75, and O2 sat 98%.  Due to responders having left the vaccine site , 911 was called at this time.  After assessment and evaluation  of the patient by EMS, it was agreed on by patient, spouse, and EMS that patient would be transferred to the Medical Center ED via ambulance for further evaluation and was discharged from the facility at 1700.
Chills, fever, extremely  lethargic , vomiting for about 3 hours  Lethargic for over a week. Fever for 2 days
STARTED TO SPACE OUT; STARTED TO SWEAT; HEARING BEGAN TO FADE WAS REPLACED WITH A LOW RINGING; LOSS OF PERIPHERAL VISION; INJECTION ARM STIFFNESS; HEARING REPLACED WITH LOW RINGING; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced started to space out, started to sweat, hearing began to fade was replaced with a low ringing, loss of peripheral vision, injection arm stiffness, and hearing replaced with low ringing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from started to space out, started to sweat, hearing began to fade was replaced with a low ringing, loss of peripheral vision, and hearing replaced with low ringing, and the outcome of injection arm stiffness was not reported. This report was non-serious.
I woke up with a red patch on my left arm  about  2" in length and 1" wide.  It was about 2" down from where I received the vaccine.  It itched a little, but not constantly. Their was swelling in the red patch.  The itching was mostly in the morning.  I didn't do anything about it, just kept an eye to see if it grew. It might have grown a little more during that day.  Two days later the redness and swelling was still there, but it seems to be dissipating.  I didn't record when the redness and swelling stopped.  It probably stayed red for about 3 days, although I can still see where it was.
1. episodes of limpness; 2. high pitched crying inc 3 hrs; 3. according to mom, MD told her child had a h/a also;
40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge; No adverse event; 40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge), PRODUCT STORAGE ERROR (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge), PRODUCT STORAGE ERROR (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  It was reported that the vaccine dose would be either 1st or 2nd. Vaccines were stored in the fridge on 30-Jun-2021. The patient did not report any side effects.  BUD was reported as 30 Jul 2021.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-698994 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-698994:Master Case ID
No adverse effects; a patient inadvertently received a 4th dose of GARDASIL 9 on 31-OCT-2019; This spontaneous report was received from a nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 31-OCT-2019, the patient was inadvertently vaccinated with 4th dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot number: R028386, expiration date: 27-APR-2021, at a dose of 0.5 milliliter (mL) (strength, route of administration and anatomical location was not reported) for prophylaxis (extra dose administered). No adverse effects were reported. No product quality complaints were involved.
This case was reported by a consumer and described the occurrence of adverse event in a adult patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of adverse event (1st dose received on an unknown date for tolerance refer case US2018GSK189845). On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse event. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient stated that the patient received shingles shot, and experienced severe side effects and said that no one in the pharmacy told him /her about.
This spontaneous report as received from a nurse refers to a 5 months 24 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
she had really bad chest pain; she is not hypoglycemic and doesn't have diabetes but her her blood sugar kept dropping; had diarrhea; vomiting; red patch on her arm; still very itchy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 23-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red patch on her arm), CHEST PAIN (she had really bad chest pain), BLOOD GLUCOSE DECREASED (she is not hypoglycemic and doesn't have diabetes but her her blood sugar kept dropping), DIARRHOEA (had diarrhea) and PRURITUS (still very itchy) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypoglycemia.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced RASH ERYTHEMATOUS (red patch on her arm) and PRURITUS (still very itchy). On an unknown date, the patient experienced CHEST PAIN (she had really bad chest pain), BLOOD GLUCOSE DECREASED (she is not hypoglycemic and doesn't have diabetes but her her blood sugar kept dropping), DIARRHOEA (had diarrhea) and VOMITING (vomiting). At the time of the report, RASH ERYTHEMATOUS (red patch on her arm), CHEST PAIN (she had really bad chest pain), BLOOD GLUCOSE DECREASED (she is not hypoglycemic and doesn't have diabetes but her her blood sugar kept dropping), DIARRHOEA (had diarrhea), PRURITUS (still very itchy) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Medical Asistant administered Varicella and Proquad resulting in patient recieveing 2 varicella doses.
He caught COVID around New Years Day of 2022 and then May2022.; He caught COVID around New Years Day of 2022 and then May2022.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD-2023-722629 (Moderna).  A 65-year-old male patient received BNT162b2 (BNT162B2), on 02Apr2021 as dose 1, single (Batch/Lot number: unknown), on 29Apr2021 as dose 2, single (Batch/Lot number: unknown) and on 17Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Allergy: sulfa" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "not recovered" and all described as "He caught COVID around New Years Day of 2022 and then May2022.". The events "he caught covid around new years day of 2022 and then may2022." required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: Positive, notes: COVID two months ago; SARS-CoV-2 test: Negative. Clinical course: He had COVID twice. Both times it started with a sore throat. The last time he caught COVID, he tested negative at the hospital at the emergency room. He called his doctor two months later. They did an antibody test, and the doctor told him he had COVID two months ago. He had to see neuro because of the side effects from the second time he caught COVID. He had all kinds of side effects. He caught COVID around New Years Day of 2022 and then May2022. The patient states he didn't have any side effects from his Pfizer doses (as reported).   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021400626 same patient /drug different dose number /AE;
Information has been received from a physician concerning a 15 month old child who on an unspecified date was vaccinated with a dose of 0.5ml of PRO-QUAD. Subsequently, the patient experienced a seizure 7-10 days after receiving the vaccination. Medical attention was sought and the patient was hospitalized. It was unspecified if lab studies were performed. It was noted that the patient recovered on an unspecified date. There was no product quality complaint involved. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY 11/4/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
09:25JAW MUSCLES TIGHTENING/ 09:35NAUSEA/VOMITING
I had the second shot of Covid the Pfizershot. And I was paralyzed and was in the hospital; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: PARALYSIS (hospitalization, medically significant), outcome "unknown", described as "I had the second shot of Covid the Pfizershot. And I was paralyzed and was in the hospital". Therapeutic measures were taken as a result of paralysis. Clinical course: Caller called in to find out if Pfizer could provide them with financial assistance for a prescription the caller received from their HCP for a hospital bed. During the call caller stated. I had the second shot of Covid the Pfizer shot. And I was paralyzed and was in the hospital and still going to therapy and I got a prescription from the doctor to still get a bed, a hospital bed. Caller later stated on the call. The blood has to go into my legs better, and my head has to get more breathing and a little bit of the head has to be up in the bed and then the feet have to be up. Note: The patients date of birth was not provided during the call. Note: The reporters address and telephone number were not provided during the call. Note: During the call caller stated their last name but it was inaudible, unable to capture the callers last name for the call.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore arm on injection site. Next day, headache, body aches and tired for about 3 days. Twitch in left eye from day 2 and still happening. No treatment needed medically so far.